These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33185038)

  • 21. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hair testing for doping agents. What is known and what remains to do.
    Kintz P; Gheddar L; Ameline A; Arbouche N; Raul JS
    Drug Test Anal; 2020 Mar; 12(3):316-322. PubMed ID: 31943812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and type of adverse analytical findings in athletics: Differences among disciplines.
    Aguilar-Navarro M; Salinero JJ; Muñoz-Guerra J; Plata MDM; Del Coso J
    Drug Test Anal; 2021 Aug; 13(8):1561-1568. PubMed ID: 33982423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical strategy for detecting doping agents in hair.
    Thieme D; Grosse J; Sachs H; Mueller RK
    Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.
    Thevis M; Krug O; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2017 Aug; 31(15):1290-1296. PubMed ID: 28508503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing.
    Thevis M; Piper T; Thomas A
    J Pharm Biomed Anal; 2021 Oct; 205():114312. PubMed ID: 34391136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doping detection in animals: A review of analytical methodologies published from 1990 to 2019.
    Moreira F; Carmo H; Guedes de Pinho P; Bastos ML
    Drug Test Anal; 2021 Mar; 13(3):474-504. PubMed ID: 33440053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.
    Aguilar-Navarro M; Salinero JJ; Muñoz-Guerra J; Plata MDM; Del Coso J
    Subst Use Misuse; 2020; 55(8):1361-1369. PubMed ID: 32186429
    [No Abstract]   [Full Text] [Related]  

  • 31. Current role of LC-MS(/MS) in doping control.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2011 Aug; 401(2):405-20. PubMed ID: 21424519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential role of oral fluid in antidoping testing.
    Anizan S; Huestis MA
    Clin Chem; 2014 Feb; 60(2):307-22. PubMed ID: 24153253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical aspects in doping control: challenges and perspectives.
    Badoud F; Guillarme D; Boccard J; Grata E; Saugy M; Rudaz S; Veuthey JL
    Forensic Sci Int; 2011 Dec; 213(1-3):49-61. PubMed ID: 21824736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of legal and illegal stimulating agents in sports.
    Deventer K; Roels K; Delbeke FT; Van Eenoo P
    Anal Bioanal Chem; 2011 Aug; 401(2):421-32. PubMed ID: 21479548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control.
    Ahrens BD; Starcevic B; Butch AW
    Methods Mol Biol; 2012; 902():115-28. PubMed ID: 22767112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modern techniques for the determination of anabolic-androgenic steroid doping in the horse.
    McKinney AR
    Bioanalysis; 2009 Jul; 1(4):785-803. PubMed ID: 21083138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.